Intraoperative blood loss in female patients with adolescent idiopathic scoliosis during different phases of the menstrual cycle

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Li, Chao ^a   Xie, Yang ^a   Li, Zhikun ^a   Yang, Mingyuan ^a   Sun, Xiaofei ^a   Fan, Jianping ^a   Zhu, Honglei Yi Xiaodong ^b   Wang, Chuanfeng ^a   Li, Ming ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b Department of Orthopedics Changhai Hospital Second Military Medical University ^*

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN;

ADOLESCENT; ADOLESCENT IDIOPATHIC SCOLIOSIS; ARTICLE; BODY HEIGHT; BODY WEIGHT; COBB ANGLE; CONTROLLED STUDY; FEMALE; FIBRINOGEN BLOOD LEVEL; FOLLICULAR PHASE; HUMAN; KRUSKAL WALLIS TEST; LUTEAL PHASE; MAJOR CLINICAL STUDY; MEDICAL RECORD; MENSTRUAL CYCLE; OPERATIVE BLOOD LOSS; OSTEOTOMY; PARTIAL THROMBOPLASTIN TIME; PEDICLE SCREW; PROTHROMBIN TIME; RETROSPECTIVE STUDY; SPINE FUSION; ADVERSE EFFECTS; BLOOD; BLOOD LOSS, SURGICAL; ORTHOPEDIC SURGERY; PATHOPHYSIOLOGY; SCOLIOSIS;

ADOLESCENT; BLOOD LOSS, SURGICAL; FEMALE; FIBRINOGEN; HUMANS; MENSTRUAL CYCLE; ORTHOPEDIC PROCEDURES; SCOLIOSIS;

EID: 84913535520     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0112499     Document Type: Article

References (47)

1. Weinstein SL, Dolan LA, Cheng JC, Danielsson A, Morcuende JA (2008) Adolescent idiopathic scoliosis. The Lancet 371: 1527-1537.
2. Luk KD, Lee CF, Cheung KM, Cheng JC, Ng BK, et al. (2010) Clinical effectiveness of school screening for adolescent idiopathic scoliosis: a large population-based retrospective cohort study. Spine (Phila Pa 1976) 35: 1607-1614.
3. Raggio CL (2006) Sexual dimorphism in adolescent idiopathic scoliosis. Orthop Clin North Am 37: 555-558.
4. Hresko MT (2013) Clinical practice. Idiopathic scoliosis in adolescents. N Engl J Med 368: 834-841.
5. Elgafy H, Bransford RJ, McGuire RA, Dettori JR, Fischer D (2010) Blood loss in major spine surgery: are there effective measures to decrease massive hemorrhage in major spine fusion surgery? Spine 35: S47.
6. Carreon LY, Puno RM, Lenke LG, Richards BS, Sucato DJ, et al. (2007) Non-neurologic complications following surgery for adolescent idiopathic scoliosis. The Journal of Bone & Joint Surgery 89: 2427-2432.
7. Gill JB, Chin Y, Levin A, Feng D (2008) The Use of Antifibrinolytic Agents in Spine SurgeryA Meta- Analysis. The Journal of Bone & Joint Surgery 90: 2399-2407.
8. Tzortzopoulou A, Cepeda MS, Schumann R, Carr DB (2008) Antifibrinolytic agents for reducing blood loss in scoliosis surgery in children. Cochrane Database Syst Rev 3.
9. Aubourg R, Putzolu J, Bouche S, Galmiche H, Denis C, et al. (2011) Surgical hemostatic agents: Assessment of drugs and medical devices. Journal of Visceral Surgery 148: e405-e408.
10. Knol HM, Kemperman RF, Kluin-Nelemans HC, Mulder AB, Meijer K (2008) Haemostatic variables during normal menstrual cycle. Thromb Haemost 99: 1019-1029.
11. Ibrahimi E, Koni M (2014) Effects of estrogens and progestagens on the primary variables of haemostasis. International Journal of Reproduction, Contraception, Obstetrics and Gynecology 3: 31- 33.
12. Daly L, Bonnar J (1990) Comparative studies of 30 mg ethinyl estradiol combined with gestodene and desogestrel on blood coagulation, fibrinolysis, and platelets. American journal of obstetrics and gynecology 163: 430-437.
13. Luyer M, Khosla S, Owen W, Miller V (2001) Prospective randomized study of effects of unopposed estrogen replacement therapy on markers of coagulation and inflammation in postmenopausal women. Journal of Clinical Endocrinology & Metabolism 86: 3629-3634.
14. Fruzzetti F, Bitzer J (2010) Review of clinical experience with estradiol in combined oral contraceptives. Contraception 81: 8-15.
15. Prisco D, Ciuti G, Falciani M (2005) Hemostatic changes in normal pregnancy; haematologica reports; 1(10): 1-5
16. Kujovich JL (2004) Hormones and pregnancy: thromboembolic risks for women. British journal of haematology 126: 443-454.
17. Bjerkreim I, Steen H, Brox JI (2007) Idiopathic scoliosis treated with Cotrel-Dubousset instrumentation: evaluation 10 years after surgery. Spine 32: 2103-2110.
18. Wang Y, Fei Q, Qiu G, Lee CI, Shen J, et al. (2008) Anterior spinal fusion versus posterior spinal fusion for moderate lumbar/thoracolumbar adolescent idiopathic scoliosis: a prospective study. Spine 33: 2166-2172.
19. Ialenti MN, Lonner BS, Verma K, Dean L, Valdevit A, et al. (2013) Predicting Operative Blood Loss During Spinal Fusion for Adolescent Idiopathic Scoliosis. Journal of Pediatric Orthopaedics 33: 372-376.
20. Klein HG, Anstee DJ (2013) Mollison's blood transfusion in clinical medicine: John Wiley & Sons.
21. van Rooijen M, Silveira A, Thomassen S, Hansson L, Rosing J, et al. (2007) Rapid activation of haemostasis after hormonal emergency contraception. Thrombosis and Haemostasis-Stuttgart- 97: 15.
22. Norris LA, Bonnar J (1997) 9 Haemostatic changes and the oral contraceptive pill. Bailliére's clinical obstetrics and gynaecology 11: 545-564.
23. Miller CH, Dilley AB, Drews C, Richardson L, Evatt B (2002) Changes in von Willebrand factor and factor VIII levels during the menstrual cycle. Thromb Haemost 87: 1082-1083.
24. Kadir RA, Economides DL, Sabin CA, Owens D, Lee CA (1999) Variations in coagulation factors in women: effects of age, ethnicity, menstrual cycle and combined oral contraceptive. Thrombosis and Haemostasis-Stuttgart- 82: 1456-1461.
25. Blombäck M, Landgren B, Stiernholm Y, Andersson O (1997) The effect of progesterone on the haemostatic mechanism. Thrombosis and haemostasis 77: 105-108.
26. Mandalaki T, Louizou C, Dimitriadou C, Symeonidis P (1980) Variations in factor VIII during the menstrual cycle in normal women. The New England journal of medicine 302: 1093-1094.
27. Feuring M, Christ M, Roell A, Schueller P, Losel R, et al. (2002) Alterations in platelet function during the ovarian cycle. Blood coagulation & fibrinolysis 13: 443-447.
28. Giardina E-GV, Chen HJ, Sciacca RR, Rabbani LE (2004) Dynamic variability of hemostatic and fibrinolytic factors in young women. Journal of Clinical Endocrinology & Metabolism 89: 6179-6184.
29. Koh SC, Prasad R, Fong Y (2005) Hemostatic status and fibrinolytic response potential at different phases of the menstrual cycle. Clinical and applied thrombosis/hemostasis 11: 295-301.
30. Onundarson P, Gudmundsdottir B, Arnfinnsdottir A, Kjeld M, Olafsson O (2001) Von Willebrand factor does not vary during normal menstrual cycle. Thrombosis and haemostasis 85: 183-184.
31. Cederblad G, Hahn L, Korsan-Bengtsen K, Pehrsson N, Rybo G (1977) Variations in blood coagulation, fibrinolysis, platelet function and various plasma proteins during the menstrual cycle. Pathophysiology of Haemostasis and Thrombosis 6: 294-302.
32. Bolis P, Franchi M, Marino L, Paganelli A, Sampaolo P (1982) Serial detection of plasma-factor XIII levels during the ovulatory cycle and estroprogestative contraception. Clinical and Experimental Obstetrics and Gynecology 9: 22-25.
33. Larsen L, Andersen H, Hansen A, Andersen O (1996) Variation in risk indicators of cardiovascular disease during the menstrual cycle: an investigation of within-subject variations in glutathione peroxidase, haemostatic variables, lipids and lipoproteins in healthy young women. Scandinavian journal of clinical & laboratory investigation 56: 241-249.
34. Dapper D, Didia B (2002) Haemorheological changes during the menstrual cycle. East African medical journal 79: 181-183.
35. Lebech A-M, Kjaer A (1989) Lipid metabolism and coagulation during the normal menstrual cycle. Hormone and metabolic research 21: 445-448.
36. Ricci G, Cerneca F, Simeone R, Pozzobon C, Guarnieri S, et al. (2004) Impact of highly purified urinary FSH and recombinant FSH on haemostasis: an open-label, randomized, controlled trial. Human Reproduction 19: 838-848.
37. Solerte SB, Fioravanti M, Spinillo A, Ferrari E, Guaschino S (1988) Association between hormonal and haemorheological changes during the menstrual cycle in healthy women. BJOG: An International Journal of Obstetrics & Gynaecology 95: 1305-1308.
38. Repina MA, Korzo M, Zinina TA (2002) Effect of hormone replacement therapy with femoston on hemostasis in peri-and postmenopausal women. Medical Science Monitor 8: PI78-PI84.
39. Roell A, Schueller P, Schultz A, Losel R, Wehling M, et al. (2007) Effect of oral contraceptives and ovarian cycle on platelet function. Platelets 18: 165-170.
40. Blombäck M, Eneroth P, Landgren B, Lagerström M, Anderson O (1992) On the intraindividual and gender variability of haemostatic components. Thrombosis and haemostasis 67: 70-75.
41. Sitruk-Ware R, Nath A (2013) Characteristics and metabolic effects of estrogen and progestins contained in oral contraceptive pills. Best Practice & Research Clinical Endocrinology & Metabolism 27: 13-24.
42. Cleuren AC, van der Linden IK, de Visser YP, Wagenaar GT, Reitsma PH, et al. (2010) 17α- Ethinylestradiol rapidly alters transcript levels of murine coagulation genes via estrogen receptor α. Journal of Thrombosis and Haemostasis 8: 1838-1846.
43. Guay J, Haig M, Lortie L, Guertin M-C, Poitras B (1994) Predicting blood loss in surgery for idiopathic scoliosis. Canadian journal of anaesthesia 41: 775-781.
44. Nuttall GA, Horlocker TT, Santrach PJ, Oliver Jr WC, Dekutoski MB, et al. (2000) Predictors of blood transfusions in spinal instrumentation and fusion surgery. Spine 25: 596-601.
45. Jain A, Njoku DB, Sponseller PD (2012) Does patient diagnosis predict blood loss during posterior spinal fusion in children? Spine 37: 1683-1687.
46. Paraskevaidis E, Davidson EJ, Koliopoulos G, Alamanos Y, Lolis E, et al. (2002) Bleeding after loop electrosurgical excision procedure performed in either the follicular or luteal phase of the menstrual cycle: a randomized trial. Obstetrics & Gynecology 99: 997-1000.
47. He S, Silveira A, Hamsten A, Blombäck M, Bremme K (1999) Haemostatic, endothelial and lipoprotein parameters and blood pressure levels in women with a history of preeclampsia. Thrombosis And Haemostasis-Stuttgart- 81: 538-542.